# Unknown Method

Luminescence-based detection of cellular ATP content

## Method Details

**Vendor:** Promega

**Catalog Number:** G9242

**Catalog Webpage:** [https://nld.promega.com/products/cell-health-assays/cell-viability-and-cytotoxicity-assays/celltiter_glo-2_0-assay/?tabset0=0](https://nld.promega.com/products/cell-health-assays/cell-viability-and-cytotoxicity-assays/celltiter_glo-2_0-assay/?tabset0=0)

**VHP4Safety Workflow Stage:** AOP

**Workflow Substage:** Mitochondrial dysfunction

**Case Study:** parkinson

**Regulatory Question:** Q1

## Additional Information

**Method:** CellTiter-Glo® 2.0 assay for detection of cellular ATP content

**Assay Name:** CellTiter-Glo® 2.0 Cell Viability Assay

**Data Producer:** Julia Meerman

**Relevant Aop Wiki Key Event(S) To The Assay:** KE177

**Relevant Aop Wiki Adverse Outcome Pathway(S) To The Assay:** AOP464

**Https:** [https//nld.promega.com/products/cell-health-assays/cell-viability-and-cytotoxicity-assays/celltiter_glo-2_0-assay/?tabset0=0](https//nld.promega.com/products/cell-health-assays/cell-viability-and-cytotoxicity-assays/celltiter_glo-2_0-assay/?tabset0=0)

**Available Sop Or Protocol:** No response

**Ontology Term:** No response

---

*Generated from issue #168 on 2025-12-03*
